Brian Anderson

About the Author Brian Anderson


B.Riley Financial Initiates a Buy Rating on Entera Bio (ENTX)

B.Riley Financial analyst Kalpit Patel initiated coverage with a Buy rating on Entera Bio (ENTX) yesterday and set a price target of $9.

Avita Medical (RCEL) Gets a Buy Rating from BTIG

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Avita Medical (RCEL), with a price target of $37.00.

BW Offshore (BGSWF) Receives a Buy from Kepler Capital

Kepler Capital analyst Kevin Roger maintained a Buy rating on BW Offshore (BGSWF) on June 14 and set a price target of NOK62.00.

Kepler Capital Believes Compagnie Générale des Établissements Michelin (MGDDF) Still Has Room to Grow

Kepler Capital analyst Thomas Besson maintained a Buy rating on Compagnie Générale des Établissements Michelin (MGDDF) on June 14 and set a price …

ENGIE SA (ENGIY) Receives a Buy from Kepler Capital

In a report issued on June 14, Ingo Becker from Kepler Capital maintained a Buy rating on ENGIE SA (ENGIY), with a price …

PubMatic (PUBM) Gets a Buy Rating from RBC Capital

In a report issued on June 14, Matthew Swanson from RBC Capital maintained a Buy rating on PubMatic (PUBM), with a price target …

RBC Capital Believes Earthstone Energy (ESTE) Won’t Stop Here

In a report issued on June 14, Scott Hanold from RBC Capital maintained a Buy rating on Earthstone Energy (ESTE), with a price …

Oppenheimer Sticks to Their Hold Rating for Tilray (TLRY)

Oppenheimer analyst Rupesh Parikh maintained a Hold rating on Tilray (TLRY) today. The company’s shares closed last Tuesday at $17.

TCR2 Therapeutics (TCRR) Gets a Buy Rating from Mizuho Securities

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on TCR2 Therapeutics (TCRR) today and set a price target of $51.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts